Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04743765 · ClinicalTrials.gov registry record · NA
HIP Fracture Accelerated Surgical TreaTment And Care tracK 2 Trial
A NA study of Hip Fractures and Myocardial Injury, sponsored by Population Health Research Institute.
- Recruiting
- Registry status
- NA
- Development phase
- 1,100
- Enrollment target
- 20
- Study locations
NCT04743765: Recruiting NA study of Hip Fractures and Myocardial Injury, sponsored by Population Health Research Institute.
NCT04743765 is a NA study of Hip Fractures and Myocardial Injury that is actively recruiting participants, run by Population Health Research Institute. The registered enrollment target is 1,100 participants, above the 548-participant average among 15 other Hip Fractures trials with a reported enrollment target (101% higher). The trial reports 20 study locations across 18 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04743765, a NA study of Hip Fractures and Myocardial Injury, is actively recruiting participants, sponsored by Population Health Research Institute.
- RECRUITING
- Registry status
- NA
- Development phase
- 1,100 participants
- Enrollment target
- 20
- Study locations
Study Summary
The HIP ATTACK-2 trial is a multicentre, international, parallel group randomized controlled trial to determine whether accelerated surgery for hip fracture in patients with acute myocardial injury is superior to standard care in reducing death at 90 days after randomization. The trial will also assess secondary outcomes at 90 days after randomization: inability to independently walk 3 metres, time to first mobilization (first standing and first full weight bear), composite and individual assessment of major complications (e.g., mortality, non-fatal myocardial infarction, acute congestive heart failure, and stroke), delirium, length of stay, pain, and quality of life.
Primary Outcome
Death due to all causes
Conditions Studied
Interventions
- OTHER Accelerated medical clearance and surgery
Study Locations (20)
Maryland
- University of Maryland - Baltimore
- Sinai Hospital of Baltimore - Baltimore
Massachusetts
- Tufts Medical Center - Boston
- Lahey Hospital and Medical Center - Burlington
Arizona
- Chandler Regional Medical Center - Chandler
California
- The Regents of the University of California - Davis
Connecticut
- Yale New Haven Hospital - New Haven
Georgia
- Emory University at Grady Memorial Hospital - Atlanta
Michigan
- University of Michigan - Ann Arbor
Minnesota
- Mayo Clinic - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,100 participants |
| Start Date | 2021-11-22 |
| Est. Completion | 2027-05-31 |
| Phase | NA |
What NCT04743765 shows while recruiting
NCT04743765 is an interventional study that assigns participants to a tested intervention. Its 1,100 participants enrollment target places it among the larger protocols in the corpus, above the 548-participant average among 15 other Hip Fractures trials with a reported enrollment target (101% higher).
The record links to 2 conditions, with Hip Fractures appearing as the primary indexed condition, and to 1 intervention - of which Accelerated medical clearance and surgery is the first listed.
NCT04743765 names 20 study sites across 18 states, led by Maryland, Massachusetts, Arizona.
Frequently Asked Questions
What is clinical trial NCT04743765 about?
NCT04743765 is a clinical study titled "HIP Fracture Accelerated Surgical TreaTment And Care tracK 2 Trial". The HIP ATTACK-2 trial is a multicentre, international, parallel group randomized controlled trial to determine whether accelerated surgery for hip fracture in patients with acute myocardial injury is superior to standard care in reducing death at 90 days after randomization. The trial will also ass...
What is the current status of trial NCT04743765?
This trial is currently recruiting. It is a NA study. The enrollment target is 1,100 participants. The study started on 2021-11-22. Estimated completion is 2027-05-31.
What conditions does trial NCT04743765 study?
This clinical trial studies the following conditions: Hip Fractures, Myocardial Injury.
What interventions are being tested in trial NCT04743765?
The interventions under investigation include: Accelerated medical clearance and surgery (OTHER).
Who is sponsoring clinical trial NCT04743765?
This trial is sponsored by Population Health Research Institute, which has 21 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04743765 being conducted?
This trial has 20 study locations across Arizona, California, Connecticut, Georgia, Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hip Fractures
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04743765's enrollment target sits among peer trials
1,100 4th of 15 higher than 12 of 15 other Hip Fractures trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hip Fractures trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Evaluating a Strategy to Improve Pre-Anesthesia Care Discussions (My Anesthesia Choice-Hip Fracture)
RECRUITING · NA
-
Cervical Myelopathy in Hip Fracture Patients
RECRUITING · NA
-
PENG vs Femoral Block for Hip Fracture Analgesia
RECRUITING · NA
-
Evaluating the Efficacy of a Mobile Application in Postoperative Rehabilitation
RECRUITING · NA
-
The Role of Blood Flow Restriction Therapy in Postoperative Elderly Patients With Hip Fracture
ACTIVE NOT RECRUITING · NA
-
Utility of Cortical Bone Tissue Properties in the Assessment of Fracture Risk
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00710112 · 1,100 participants
Genetic Variants and Susceptibility to Diseases of Prematurity in Very Low Birth-Weight Infants
- NCT02688517 · 1,100 participants
Targeted Genomic Analysis of Blood and Tissue Samples From Patients With Cancer
- NCT05638581 · 1,100 participants · Phase 3
Trauma Resuscitation With Low-Titer Group O Whole Blood or Products
- NCT06066502 · 1,100 participants · Phase 3
Precision Ventilation vs Standard Care for Acute Respiratory Distress Syndrome
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI